Skip to main content

Table 2 Unadjusted associations between SNPs from surfactant protein A alleles (SFTPA1,SFTPA2) and respiratory symptomsa during the first year of life for white infants at risk for developing asthma. (CT and MA, 1998 – 2000)

From: Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes

  

Persistent cough (days/year) (%)

Wheeze (days/year) (%)

Characteristic

n (%)

0

1 – 7

8 – 14

15 – 21

22 – 28

> 28

p-valueb

0

1 – 7

8 – 14

15 – 21

22 – 28

> 28

p-valueb

White infants N (%)

221

109 (49.3)

30 (13.6)

19 (8.6)

12 (5.4)

10 (4.5)

41 (18.6)

 

119 (54.3)

49 (22.4)

17 (7.8)

7 (3.2)

6 (2.7)

21 (9.6)

 

SFTPA1 c

               

   aa 19 (rs1059047)

               

CC

1 (0.4)

              

CT

42 (19.0)

46.5

7.0

11.6

7.0

2.3

25.6

0.15

44.2

18.6

11.6

4.6

7.0

14.0

0.02

TT

178 (80.5)

49.7

14.9

8.0

5.1

5.1

17.1

 

56.6

23.1

6.9

2.9

1.7

8.7

 

   aa 50 (rs1136450)

               

CC

48 (21.4)

              

CG

103 (46.0)

51.7

10.9

8.2

6.1

3.4

19.7

0.50

53.4

22.6

8.9

2.7

3.4

8.9

0.51

GG

73 (32.6)

45.2

17.8

9.6

4.1

6.8

16.4

 

55.6

22.2

5.6

4.2

1.4

11.1

 

   aa 62 (rs1136451)

               

GG

5 (2.2)

              

AG

61 (27.5)

45.3

7.8

14.1

6.2

3.1

23.4

0.11

46.9

21.9

10.9

3.1

6.2

10.9

0.07

AA

156 (70.3)

51.3

15.6

6.5

4.6

5.2

16.9

 

57.9

21.7

6.6

3.3

1.3

9.2

 

   aa 133 (rs1059057)

               

GG

1 (0.4)

              

AG

38 (16.9)

36.8

7.9

13.2

7.9

2.6

31.6

0.02

39.5

18.4

10.5

5.3

10.5

15.8

0.003

AA

186 (82.7)

51.9

14.8

7.6

4.9

4.9

15.8

 

57.5

23.2

7.2

2.8

1.1

8.3

 

   aa 219 (rs4253527)

               

TT

1 (0.4)

              

CT

34 (15.1)

52.9

11.8

20.6

2.9

0.0

11.8

0.12

55.9

29.4

11.8

0.0

0.0

2.9

0.06

CC

190 (84.4)

48.7

13.9

6.4

5.9

5.4

19.8

 

54.0

21.1

7.0

3.9

3.2

10.8

 

   SFTPA2 c

               

aa 9 (rs1059046)

               

CC

42 (18.7)

              

AC

109 (48.4)

52.4

11.6

9.5

4.1

3.4

19.0

0.26

55.1

21.1

8.8

2.0

3.4

9.5

0.50

AA

74 (32.9)

43.2

17.6

6.8

8.1

6.7

17.6

 

52.8

25.0

5.6

5.6

1.4

9.7

 

   aa 91 (rs17886395)

               

CC

3 (1.4)

              

CG

57 (25.7)

50.8

8.5

10.2

5.1

3.4

22.0

0.33

54.2

18.6

6.8

3.4

8.5

8.5

0.23

GG

162 (73.0)

49.1

15.1

8.2

5.7

5.0

17.0

 

54.8

23.6

8.3

3.2

0.6

9.6

 

   aa 140 (rs1965707)

               

TT

13 (5.8)

              

CT

87 (38.8)

53.1

15.3

8.2

2.0

2.0

19.4

0.15

53.1

24.5

10.2

3.1

2.0

7.1

0.24

CC

124 (55.4)

45.9

12.3

9.0

8.2

6.6

18.0

 

55.0

20.8

5.8

3.3

3.3

11.7

 

   aa 223 (rs1965708)

               

AA

7 (3.1)

              

AC

71 (31.6)

54.0

11.8

9.2

2.7

4.0

18.4

0.27

55.3

23.7

9.2

4.0

1.3

6.6

0.18

CC

147 (65.3)

46.9

14.5

8.3

6.9

4.8

18.6

 

53.8

21.7

7.0

2.8

3.5

11.2

 
  1. aN = 221 infants had data for persistent cough and N = 219 for wheeze during the first year of life. bp-values from test for trend: Cochran-Armitage exact test (1-sided). Minor homozygotes and heterozygous alleles were combined and compared to the dominant homozygous group. Significant p-values (p < 0.05) in bold-face type. c SNPs were in Hardy-Weinberg equilibrium. rs numbers are given in parentheses next to each amino acid.
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us